There is evidence to suggest that SSTR-5 is expressed in neuroendocrine tumors and has an antiproliferative role.19,22 However, this did not translate to improved survival outcomes in cases with SSTR-5 score >1 in the present analysis of PNETs. Here, SSTR5 is linked to neuroendocrine neoplasm.